Entrada Therapeutics, Inc.
NASDAQ:TRDA
Overview | Financials
Company Name | Entrada Therapeutics, Inc. |
Symbol | TRDA |
Currency | USD |
Price | 12.49 |
Market Cap | 467,375,488 |
Dividend Yield | 0% |
52-week-range | 11.35 - 21.79 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Dipal Doshi |
Website | https://www.entradatx.com |
An error occurred while fetching data.
About Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD